Human gene
SGCD sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2122 | Muscular dystrophy, limb-girdle, type R6 (LGMDR6) | dog | SGCD | one to one | Target evidence |
60.9
|
| 2211 | Cardiomyopathy, hypertrophic, SGCD-related | pig | SGCD | one to one | Target evidence |
39.1
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| autosomal recessive limb-girdle muscular dystrophy type 2F | MONDO:0011028 | 0.77 | 658 |
| dilated cardiomyopathy 1L | MONDO:0011702 | 0.72 | 282 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.